AstraZeneca International - pharmaceutical company, prescription drugs, medicine manufacturers

Reference code :: wf349
Published date :: 12 October 2000
Expired date :: 28 February 2028

Two landmark studies reported today in the New England Journal of Medicine show encouraging new data on asthma management and children's growth with long-term use of Pulmicortâ (budesonide), an inhaled corticosteroid, made by AstraZeneca. Given the chronic nature of persistent asthma and the likely need for medications to be used for long periods of time, each of the studies -- one conducted by the National Institutes of Health (NIH), the other by world-renown asthma specialists in Denmark -- examined the long-term effects of the inhaled corticosteroid, budesonide.